162 related articles for article (PubMed ID: 9249859)
1. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
[TBL] [Abstract][Full Text] [Related]
2. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
3. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
5. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
[TBL] [Abstract][Full Text] [Related]
7. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
8. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
10. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
11. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses.
Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A
Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707
[TBL] [Abstract][Full Text] [Related]
12. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
13. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
14. Altered newborn gender distribution in patients with low mid-trimester maternal serum human chorionic gonadotropin (MShCG).
Santolaya-Forgas J; Meyer WJ; Burton BK; Scommegna A
J Matern Fetal Med; 1997; 6(2):111-4. PubMed ID: 9086428
[TBL] [Abstract][Full Text] [Related]
15. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
[TBL] [Abstract][Full Text] [Related]
16. Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome.
Shenhav S; Gemer O; Volodarsky M; Zohav E; Segal S
Acta Obstet Gynecol Scand; 2003 Oct; 82(10):912-5. PubMed ID: 12956840
[TBL] [Abstract][Full Text] [Related]
17. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
18. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
